Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan

ABSTRACT Mycobacterium avium complex (MAC) is an emerging pathogen causing nontuberculous pulmonary infections globally. However, clinical treatment guidelines regard MAC as a single entity, recommending a universal anti-mycobacterial combination therapy. Our study aimed to distinguish species among...

Full description

Saved in:
Bibliographic Details
Main Authors: Hsiu-Mei Lin, Chin-Chung Shu, Chun-Hao Chen, Nan-Yu Chen, Jeng-How Yang, Chih-Hung Chen, Shih-Hong Li, Chih-Liang Wang, Chih-Teng Yu, Shu-Min Lin, Kuo-Chin Kao, Chung-Chi Huang, Cheng-Ta Yang, Jang-Jih Lu, Cheng-Hsun Chiu, Hsin-Chih Lai, Ting-Shu Wu
Format: Article
Language:English
Published: American Society for Microbiology 2025-08-01
Series:Microbiology Spectrum
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/spectrum.00309-25
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849395899739930624
author Hsiu-Mei Lin
Chin-Chung Shu
Chun-Hao Chen
Nan-Yu Chen
Jeng-How Yang
Chih-Hung Chen
Shih-Hong Li
Chih-Liang Wang
Chih-Teng Yu
Shu-Min Lin
Kuo-Chin Kao
Chung-Chi Huang
Cheng-Ta Yang
Jang-Jih Lu
Cheng-Hsun Chiu
Hsin-Chih Lai
Ting-Shu Wu
author_facet Hsiu-Mei Lin
Chin-Chung Shu
Chun-Hao Chen
Nan-Yu Chen
Jeng-How Yang
Chih-Hung Chen
Shih-Hong Li
Chih-Liang Wang
Chih-Teng Yu
Shu-Min Lin
Kuo-Chin Kao
Chung-Chi Huang
Cheng-Ta Yang
Jang-Jih Lu
Cheng-Hsun Chiu
Hsin-Chih Lai
Ting-Shu Wu
author_sort Hsiu-Mei Lin
collection DOAJ
description ABSTRACT Mycobacterium avium complex (MAC) is an emerging pathogen causing nontuberculous pulmonary infections globally. However, clinical treatment guidelines regard MAC as a single entity, recommending a universal anti-mycobacterial combination therapy. Our study aimed to distinguish species among MAC and investigate the antimicrobial susceptibility for the selection of optimal antimicrobial agents in Taiwan. Two hundred ninety-four consecutive sputum samples confirmed as MAC by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry were collected from 1 November 2015 to 31 August 2020 at Linkou Chang Gung Memorial Hospital in Taiwan. These isolates were identified through 16S rRNA gene, 23S rRNA gene, heat-shock protein 65 gene (hsp65), internal transcribed spacer, and beta subunit of RNA polymerase (rpoB) gene sequencing and phylogenetic analyses. Antimicrobial susceptibility testing (AST) was performed with 13 antimicrobial agents. The predominant pathogen identified was Mycobacterium intracellulare clade A (122/294, 41.5%), followed by M. intracellulare subsp. chimaera (87/294, 29.6%), M. intracellulare subsp. intracellulare (39/294, 13.3%), M. avium (35/294, 11.9%), and four other species (11/294, 3.7%). AST showed that clarithromycin and amikacin had high susceptibility rates against M. intracellulare clade A, M. intracellulare subsp. chimaera, M. intracellulare subsp. intracellulare, and M. avium, while linezolid and moxifloxacin exhibited higher resistance. The comparison of minimum inhibitory concentrations among species within the same antimicrobial agent showed variability in susceptibility. A diverse clonality of M. intracellulare might exist in MAC pulmonary infections in Taiwan. Among MAC species, M. avium exhibited multidrug resistance. Although international guidelines recommend macrolide, ethambutol, and rifampin for treating MAC pulmonary disease, our study highlights the importance of considering species identification and regional AST results when selecting anti-mycobacterial agents.IMPORTANCEThere are more than 10 (sub)species within the Mycobacterium avium complex. According to modern biotechnology, such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, it is still difficult to differentiate the complex into specific species precisely. We utilize concatenated multi-gene sequencing to classify this complex at the (sub)species level. Indeed, we encountered poorer treatment outcomes when facing Mycobacterium avium pulmonary infections compared to other species causing pulmonary infections. Individualized anti-mycobacterial therapy should focus on each species responsible for pulmonary disease.
format Article
id doaj-art-ea905e91ee7942e69cba5f69da76dadd
institution Kabale University
issn 2165-0497
language English
publishDate 2025-08-01
publisher American Society for Microbiology
record_format Article
series Microbiology Spectrum
spelling doaj-art-ea905e91ee7942e69cba5f69da76dadd2025-08-20T03:39:28ZengAmerican Society for MicrobiologyMicrobiology Spectrum2165-04972025-08-0113810.1128/spectrum.00309-25Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in TaiwanHsiu-Mei Lin0Chin-Chung Shu1Chun-Hao Chen2Nan-Yu Chen3Jeng-How Yang4Chih-Hung Chen5Shih-Hong Li6Chih-Liang Wang7Chih-Teng Yu8Shu-Min Lin9Kuo-Chin Kao10Chung-Chi Huang11Cheng-Ta Yang12Jang-Jih Lu13Cheng-Hsun Chiu14Hsin-Chih Lai15Ting-Shu Wu16Department of Family Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanDepartment of Internal Medicine, National Taiwan University Hospital, National Taiwan University School of Medicine, , Taipei, TaiwanDepartment of Orthopedics, Chiayi Chang Gung Memorial Hospital, , Chiayi, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanDivision of Thoracic Medicine, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanDivision of Thoracic Medicine, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanDivision of Thoracic Medicine, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanDivision of Clinical Pathology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanDepartment of Medical Technology and Laboratory Science, College of Medicine, Chang Gung University, Taoyuan, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital, Taoyuan, TaiwanABSTRACT Mycobacterium avium complex (MAC) is an emerging pathogen causing nontuberculous pulmonary infections globally. However, clinical treatment guidelines regard MAC as a single entity, recommending a universal anti-mycobacterial combination therapy. Our study aimed to distinguish species among MAC and investigate the antimicrobial susceptibility for the selection of optimal antimicrobial agents in Taiwan. Two hundred ninety-four consecutive sputum samples confirmed as MAC by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry were collected from 1 November 2015 to 31 August 2020 at Linkou Chang Gung Memorial Hospital in Taiwan. These isolates were identified through 16S rRNA gene, 23S rRNA gene, heat-shock protein 65 gene (hsp65), internal transcribed spacer, and beta subunit of RNA polymerase (rpoB) gene sequencing and phylogenetic analyses. Antimicrobial susceptibility testing (AST) was performed with 13 antimicrobial agents. The predominant pathogen identified was Mycobacterium intracellulare clade A (122/294, 41.5%), followed by M. intracellulare subsp. chimaera (87/294, 29.6%), M. intracellulare subsp. intracellulare (39/294, 13.3%), M. avium (35/294, 11.9%), and four other species (11/294, 3.7%). AST showed that clarithromycin and amikacin had high susceptibility rates against M. intracellulare clade A, M. intracellulare subsp. chimaera, M. intracellulare subsp. intracellulare, and M. avium, while linezolid and moxifloxacin exhibited higher resistance. The comparison of minimum inhibitory concentrations among species within the same antimicrobial agent showed variability in susceptibility. A diverse clonality of M. intracellulare might exist in MAC pulmonary infections in Taiwan. Among MAC species, M. avium exhibited multidrug resistance. Although international guidelines recommend macrolide, ethambutol, and rifampin for treating MAC pulmonary disease, our study highlights the importance of considering species identification and regional AST results when selecting anti-mycobacterial agents.IMPORTANCEThere are more than 10 (sub)species within the Mycobacterium avium complex. According to modern biotechnology, such as matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, it is still difficult to differentiate the complex into specific species precisely. We utilize concatenated multi-gene sequencing to classify this complex at the (sub)species level. Indeed, we encountered poorer treatment outcomes when facing Mycobacterium avium pulmonary infections compared to other species causing pulmonary infections. Individualized anti-mycobacterial therapy should focus on each species responsible for pulmonary disease.https://journals.asm.org/doi/10.1128/spectrum.00309-25concatenated gene sequencesphylogenetic analysismultidrug resistancegenetic diversitycombination therapy
spellingShingle Hsiu-Mei Lin
Chin-Chung Shu
Chun-Hao Chen
Nan-Yu Chen
Jeng-How Yang
Chih-Hung Chen
Shih-Hong Li
Chih-Liang Wang
Chih-Teng Yu
Shu-Min Lin
Kuo-Chin Kao
Chung-Chi Huang
Cheng-Ta Yang
Jang-Jih Lu
Cheng-Hsun Chiu
Hsin-Chih Lai
Ting-Shu Wu
Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan
Microbiology Spectrum
concatenated gene sequences
phylogenetic analysis
multidrug resistance
genetic diversity
combination therapy
title Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan
title_full Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan
title_fullStr Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan
title_full_unstemmed Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan
title_short Heterogeneity among Mycobacterium avium complex species isolated from pulmonary infection in Taiwan
title_sort heterogeneity among mycobacterium avium complex species isolated from pulmonary infection in taiwan
topic concatenated gene sequences
phylogenetic analysis
multidrug resistance
genetic diversity
combination therapy
url https://journals.asm.org/doi/10.1128/spectrum.00309-25
work_keys_str_mv AT hsiumeilin heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chinchungshu heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chunhaochen heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT nanyuchen heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT jenghowyang heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chihhungchen heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT shihhongli heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chihliangwang heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chihtengyu heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT shuminlin heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT kuochinkao heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chungchihuang heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chengtayang heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT jangjihlu heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT chenghsunchiu heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT hsinchihlai heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan
AT tingshuwu heterogeneityamongmycobacteriumaviumcomplexspeciesisolatedfrompulmonaryinfectionintaiwan